Showing results (371-380 of 392) with videos related to

Sort By:
Pageof 40
The Journal of Biological Chemistry|July 16, 2002
Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR deltaDeborah M Muoio, Paul S MacLean, David B Lang, et al.
Neurology|December 14, 2005
Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitisR Watson, J E C Jepson, I Bermudez, et al.
Frontiers in Oncology|October 20, 2022
Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell linesJonas B Lang, Michèle C Buck, Jennifer Rivière, et al.
Arthritis Research|November 1, 2000
Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblastsF Kullmann, M Judex, W Ballhorn, et al.
Brain : a Journal of Neurology|August 1, 1997
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndromeW P Mason, F Graus, B Lang, et al.
Neurology|July 14, 2004
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitisR Watson, Y Jiang, I Bermudez, et al.
International Journal of Pediatric Otorhinolaryngology|September 28, 2021
Safety of elective paediatric surgery during the coronavirus disease 2019 pandemicF G Kavanagh, D L James, D Brinkman, et al.
Ebiomedicine|May 24, 2016
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating PolyradiculoneuropathyRaphaël Faucard, Alexandra Madeira, Nadège Gehin, et al.
Journal of Neuroimmunology|July 23, 2015
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upTobias Derfuss, François Curtin, Claudia Guebelin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsTobias Derfuss, François Curtin, Claudia Guebelin, et al.
Pageof 40